At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ECOR Electrocore LLC
Pre-Market Trading 12-24 09:18:15 EST
17.52
+2.25
+14.73%
盘前17.90
+0.38+2.17%
09:16 EST
High17.89
Low15.25
Vol212.02K
Open15.50
D1 Closing15.27
Amplitude17.29%
Mkt Cap114.84M
Tradable Cap80.40M
Total Shares6.55M
T/O3.60M
T/O Rate4.62%
Tradable Shares4.59M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Why Investors Shouldn't Be Surprised By electroCore, Inc.'s (NASDAQ:ECOR) 27% Share Price Surge
BRIEF-Electrocore To Acquire Neurometrix, Gaining Access To Its Quell Platform And Positioning Itself As A Significant Player In Non-Invasive Bioelectronic Medicine And Wellness
electroCore to Acquire NeuroMetrix, Gaining Access to Its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.